AstraZeneca reports 3 percent earnings decrease
Posted January 31st, 2008 by seher
Its pretax profit was 7.98 billion dollars as sales were 12 percent up.
AstraZeneca said that market conditions remained challenging but cost-cutting would improve profits this year.
AstraZeneca PLC is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the merger of Swedish Astra AB and British Zeneca Group PLC.
Zeneca was part of Imperial Chemical Industries prior to a demerger in 1993. AstraZeneca develops, manufactures, and sells pharmaceuticals to treat disorders in the gastrointestinal, cardiac and vascular, neurological and psychiatric, infection, respiratory, pathological inflammation and oncology areas.
Source: By Pravda.ru
View Related News
Login or Join Huliq today!
Pictures for this story
- Pickens Plan Breaks Foreign Oil Dependency At Pickensplan.com1773
- Florida School Grades Show The State In Nation's Top 15213
- Fed's New Mortgage Rules To Protect Future Homeowners177
- When Lottery Has Zero Chance172
- Obamas Pimp Out the Kids for Access Hollywood 157
- Washington Museum Presents Fritz Scholder's Art154
- Opera brings Web standards to classrooms worldwide148
- Pickens Plan Breaks Foreign Oil Dependency At Pickensplan.com12
- Fed's New Mortgage Rules To Protect Future Homeowners11
- Official: Azerbaijan's attempts endanger negotiating process7
- When Lottery Has Zero Chance6
- Florida School Grades Show The State In Nation's Top 156
- US firms a role model for fair hiring standards6
- Obamas Pimp Out the Kids for Access Hollywood 5
- Pickens Plan Breaks Foreign Oil Dependency At Pickensplan.com
- Ralph Nader To Hold Rally In Raleigh NC 7/12
- Families with children without genetic link to their parents are functioning well
- Nose Cone of A NorthWest Jet Damaged Mid-Flight
- Patients unaware of link between smoking and bladder cancer
- 98 % mastectomy patients would have reconstruction again